Skip to main content

Mankind Pharma eyes 50% revenue from chronic therapy drugs in 3 years

With the launch, the company has become the first Indian and second global firm to develop the drug, which is a generic version of Abbott's Duphaston

from Today's Paper https://ift.tt/3uYyPZa

Comments

Popular posts from this blog